Search results for "biopharmaceutical"
Article
Remote Monitoring and Big Data Advance Upstream Automation
COVID-19 as an accelerator of adoption
The COVID-19 pandemic has impacted the biopharmaceutical industry in multiple ways. It has highlighted the dependence the world has on the industry and how i…
Article
Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
By Claire Hill
The biopharmaceutical market continues to expand at a rapid pace and the demand for upstream manufacturing capacity, particularly for growth areas such as viral vectors, is growing …
Article
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
Legal experts in biopharmaceutical patent law shed some light on trends and recent news.
By Agnes Shanley
…
Article
The Challenge of Disruptive Technologies in Bioprocessing
“When we look at the biologics market dynamics for treatment of diseases, certainly the increasing demand for biopharmaceuticals and the growing R&D expenditure in biopharma companies are factors driv…
Article
Gain Efficiency in Process Development
The development of efficient manufacturing processes is a necessity for cost-effective production of biopharmaceuticals. By carefully designing and evaluating your experiments, sufficient informatio…
Article
Understanding Validation and Technical Transfer, Part 3
This third article in a three-part series (1,2) dealing with validation and technical transfer in the biopharmaceutical industry discusses validation of a non-traditional biopharmaceutical process, l…
Article
Putting Viral Clearance Capabilities to the Test
Viral clearance studies assess the capability of a downstream process to remove or inactivate potential contaminants and are based on a scale-down model of a biopharmaceutical production process. The …
Article
Industry Adoption of Single-Use Systems Remains Low
Conservative attitude
Conservative attitudes tend to dominate the pharmaceutical and biopharmaceutical industries, which have traditionally resulted in slow adoption of newer manufacturing tec…
Article
Reducing Cross-Contamination Risks in Process Chromatography
Elimination of cleaning and cleaning validation activities also leads to smaller and simpler (open ballroom) facilities for biopharmaceutical manufacturing.
Market risks can be minimized …
Article
ADC Development Robust Despite Lackluster Performance
This has not stopped ADC developers, though, and the biopharmaceutical pipeline is populated with ADC candidates under development.
The promise of conjugation
ADCs are part of a relatively new c…